Thus, there are possibilities that Alu and LINE-1 hypomethylation may be different according to breast cancer subtype or CD44+/CD24− and ALDH1+ breast cancer stem cell (BCSC) phenotypes. This evidence concerns the gene CD44 and breast carcinoma.